Liver Disease

Latest News

Blue FDA approved stamp | Imaged credit: Olivier Le Moal -
FDA Approves Resmetirom, First Treatment for NASH With Liver Fibrosis

March 14th 2024

The first medication for the treatment of nonalcoholic steatohepatitis (NASH) and liver fibrosis received accelerated approval. Previously, the only treatment available to patients was implementing lifestyle changes aimed at weight reduction.

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

August 17th 2023

Impact of Direct-Acting Antiviral Use for Chronic Hepatitis C on Health Care Costs in Medicaid: Economic Model Update

December 12th 2022

Pathological Neutrophil Migration in Cirrhosis Linked to Increased Risk of AEs

November 30th 2022

4 surgeons performing surgery
MA Beneficiaries May Be at Disadvantage for Complex Cancer Surgeries

November 21st 2022

More News

CH LogoCenter for Biosimilars Logo